[ad_1]
This Wednesday afternoon, the American newspaper The New York Times counted to Chile among the richest countries in the world in hoarding pre-orders of vaccines against covid-19, with quantities far above what it would really need to immunize its entire population.
According to the morning’s review, according to signed contracts accessed by Duke University, Unicef and the scientific analysis firm Airfinity, our country would be the sixth nation on the planet to engage in this practice, only with vaccines in clinical phase 3.
The first place was taken by Canada, with over 600% difference including pre-orders of vaccines in pre-clinical trials and also in phase 1, 2 and 3.
Canada is the United States followed with the United Kingdom (over 400%) and the entire European Union (more than 250%). After Chile were Israel, New Zealand, Hong Kong and Japan. The group was completed by Switzerland, South Korea, Kuwait, Taiwan, Italy and Panama.
Rich countries
Middle-income countries
Low income countries
“As increasing numbers of coronavirus vaccines advance their clinical studies, rich countries are fueling an extraordinary gap in access around the world, ensuring more than half of the doses that could hit the market by the end of next year “, said the Times.
And why did this happen? Because, as it was not certain which laboratory would be successful in its adventure, many rich countries signed or closed agreements with several suppliers almost at the same time.
As a result, Chile and other wealthy countries would be to blame for the low vaccination figures that poor countries would reach during 2021, which are around 20% of its people.
“The rich countries got to the front of the line and emptied the gondolas”Andrea Taylor, a Duke researcher who studied the contracts in question, told the aforementioned media.
How much are we talking about?
At press time, the Times figure in 100 million the doses ordered from Pfizer by the United States, to which are added another 500 million extra and 200 million Moderna vaccines, a company that guaranteed them an offer of 300 million additional immunizations.
Donald Trump’s country also pre-ordered 810 million doses of AstraZeneca, Johnson & Johnson, Novavax and Sanofi vaccines, with expansion deals with what that number could shoot up to 1,500 million.
UK has already requested 357 million doses of the aforementioned laboratories, in addition to Valneva. However, to all that are added an optional extra 152 million.
For its part, European Union has already insured 1,300 million, although it has the supply of 660 million vaccines if you wish.
And Chile?
Although in his publication the Times did not provide details of how much Chile has ordered so far, President Sebastián Piñera already announced on September 22 agreements that would bring the country 32.4 million doses of the covid-19 vaccine.
Specifically, he spoke of an agreement that the Ministries of Health and Foreign Affairs signed with the Covax initiative for eight million doses “of the vaccine that we choose, with the validation of the World Health Organization.”
The second deal resulted from negotiations with PfizerBioNtech, from the United States and Germany, which will offer 10 million doses – submitted for FDA approval – with a delivery schedule starting in early 2021 if all goes well.
In the third arrangement, in which the Government has already expressed its intention and made reservations, Chile will agree to 14.4 million doses of the vaccine being developed by the AstraZeneca laboratory in conjunction with the University of Oxford.
On the national network on Wednesday night, Piñera confirmed that the first 20 thousand doses of the vaccine from Pfizer and BioNtech will land on national soil during the remainder of December.
The first inoculated will be ICU workers from the Bío Bío, La Araucanía, Magallanes and Metropolitan regions, so voluntary and free.
[ad_2]
